IRIS
BELLOCCHI, MARIA CONCETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.815
AS - Asia 2.092
EU - Europa 1.814
SA - Sud America 343
Continente sconosciuto - Info sul continente non disponibili 299
AF - Africa 45
OC - Oceania 2
Totale 17.410
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.685
SG - Singapore 1.010
IT - Italia 474
CN - Cina 352
BR - Brasile 281
RU - Federazione Russa 269
HK - Hong Kong 210
DE - Germania 187
VN - Vietnam 173
SE - Svezia 162
BD - Bangladesh 122
UA - Ucraina 117
IE - Irlanda 113
FR - Francia 111
PL - Polonia 95
FI - Finlandia 82
GB - Regno Unito 82
CA - Canada 69
JP - Giappone 54
KR - Corea 38
IN - India 34
NL - Olanda 34
AR - Argentina 25
MX - Messico 22
ID - Indonesia 20
BE - Belgio 19
AT - Austria 15
CZ - Repubblica Ceca 14
ES - Italia 14
JM - Giamaica 14
TR - Turchia 14
CO - Colombia 11
ZA - Sudafrica 11
UZ - Uzbekistan 10
IQ - Iraq 9
EC - Ecuador 8
CH - Svizzera 6
MY - Malesia 6
PE - Perù 5
PH - Filippine 5
PK - Pakistan 5
AL - Albania 4
CL - Cile 4
CR - Costa Rica 4
EG - Egitto 4
GT - Guatemala 4
IL - Israele 4
KE - Kenya 4
NI - Nicaragua 4
TN - Tunisia 4
VE - Venezuela 4
A2 - ???statistics.table.value.countryCode.A2??? 3
IR - Iran 3
KZ - Kazakistan 3
MN - Mongolia 3
NG - Nigeria 3
PR - Porto Rico 3
PY - Paraguay 3
SC - Seychelles 3
TT - Trinidad e Tobago 3
AU - Australia 2
CM - Camerun 2
CY - Cipro 2
DK - Danimarca 2
DZ - Algeria 2
ET - Etiopia 2
EU - Europa 2
HU - Ungheria 2
JO - Giordania 2
LT - Lituania 2
NP - Nepal 2
RO - Romania 2
SA - Arabia Saudita 2
SV - El Salvador 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BJ - Benin 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
CD - Congo 1
CG - Congo 1
CI - Costa d'Avorio 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
EE - Estonia 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
HN - Honduras 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
Totale 17.110
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.879
Wilmington 2.722
Houston 2.450
Singapore 620
Ashburn 507
Fairfield 414
San Jose 367
Chandler 277
Ann Arbor 232
Hong Kong 204
Rome 204
Seattle 182
Beijing 162
Council Bluffs 142
Cambridge 136
Santa Clara 115
New York 114
Dublin 104
Jacksonville 98
Medford 83
Los Angeles 82
The Dalles 80
Creede 69
Kraków 69
Ho Chi Minh City 59
Buffalo 52
Tokyo 51
Helsinki 46
Milan 46
Dearborn 45
Dallas 44
Hanoi 44
Moscow 43
Lawrence 37
Munich 35
Denver 33
São Paulo 29
San Diego 26
Colorado Springs 23
Nuremberg 23
Orem 23
Brussels 19
Chicago 19
Warsaw 19
Frankfurt am Main 18
London 18
Montreal 18
Mülheim 18
Lauterbourg 17
North Bergen 17
Phoenix 17
Brooklyn 16
Zhengzhou 15
Jakarta 14
Menlo Park 12
Mountain View 12
Stockholm 12
Toronto 12
Atlanta 11
Columbus 11
Florence 11
Redondo Beach 11
Boardman 10
Chennai 10
Guangzhou 10
Mumbai 10
New Orleans 10
Redwood City 10
Washington 10
Brno 9
Miami 9
Seoul 9
Brasília 8
Johannesburg 8
Kingston 8
Mexico City 8
Amsterdam 7
Bologna 7
Boston 7
Detroit 7
Falls Church 7
Lappeenranta 7
Magenta 7
Manchester 7
Naples 7
Rio de Janeiro 7
San Francisco 7
Tashkent 7
Da Nang 6
Las Vegas 6
Palo Alto 6
Paris 6
Vienna 6
Cagliari 5
Cedarhurst 5
Dong Ket 5
Norwalk 5
Olomouc 5
Philadelphia 5
Queens 5
Totale 13.566
Salva come PNG Salva come JPEG
Nome #
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 594
Occupational HIV infection in a research laboratory with unknown mode of transmission: a case report 545
Virologic correlates of adherence to antiretroviral medications and therapeutic failure 526
Characterization of drug-resistance mutations in HIV-1 isolates from non-HAART and HAART treated patients in Burkina Faso 526
MBNL142 and MBNL143 gene isoforms, overexpressed in DM1-patient muscle, encode for nuclear proteins interacting with Src family kinases 509
Kinetics of hepatitis C virus RNA decay, quasispecies evolution and risk of virological failure during telaprevir-based triple therapy in clinical practice 506
Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro 506
Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression 499
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 494
Population variation analysis at nine loci containing expressed trinucleotide repeats 493
Effective program against mother-to-child transmission of HIV at Saint Camille Medical Centre in Burkina Faso 493
Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors 484
Macrophages and HIV infection: Therapeutical approaches toward this strategic virus reservoir 483
Incomplete APOBEC3G/F neutralization by HIV-1 Vif mutants facilitates the genetic evolution from CCR5 to CXCR4 usage 468
Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: Results from the DREAM programme 463
Q151M-mediated multinucleoside resistance: prevalence, risk factors, and response to salvage therapy 459
Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure 453
Clinical and genotypic correlates of mutation K65R in HIV-infected patients failing regimens not including tenofovir 452
Dynamics of NRTI resistance mutations during therapy interruption 450
Temporal characterization of drug resistance associated mutations in HIV-1 protease and reverse transcriptase in patients failing antiretroviral therapy 434
A recent epidemiological cluster of acute hepatitis B genotype F1b infection in a restricted geographical area of Italy 426
Temporal change in the use of genotypic resistance testing over the years 1999--2003 424
Novel human immunodeficiency virus type 1 protease mutations potentially involved in resistance to protease inhibitors 421
Multiple Hepatitis B Virus (HBV) Quasispecies and Immune-Escape Mutations Are Present in HBV Surface Antigen and Reverse Transcriptase of Patients with Acute Hepatitis B 417
Next-generation sequencing provides an added value in determining drug resistance and viral tropism in Cameroonian HIV-1 vertically infected children 414
Ultradeep sequencing detection of the R263K integrase inhibitor drug resistance mutation 393
Focus on recently developed assays for detection of resistance/sensitivity to reverse transcriptase inhibitors 320
HCV resistance compartmentalization within tumoral and non-tumoral liver in transplanted patients with hepatocellular carcinoma 275
Different patterns of HIV-1 replication in MACROPHAGES is led by co-receptor usage 250
NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients 220
Establishment of a Seronegative Occult Infection With an Active Hepatitis B Virus Reservoir Enriched of Vaccine Escape Mutations in a Vaccinated Infant After Liver Transplantation 178
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry 172
Frequency of atypical mutations in the spike glycoprotein in SARS-CoV-2 circulating from July 2020 to July 2022 in central Italy: a refined analysis by Next Generation Sequencing 171
Long-term SARS-CoV-2 infection associated with viral dissemination in different body fluids Including bile in two patients with acute cholecystitis 168
Characterization of HBV and HCV minority quasispecies by ultra-deep pyrosequencing analysis: impact on pathogenicity and response to antiviral drugs 166
HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015-21 163
Viral resistance burden and APOBEC editing correlate with virological response in heavily treatment-experienced people living with multi-drug resistant HIV 154
Impact of analytical treatment interruption on burden and diversification of HIV peripheral reservoir: a pilot study 147
A high genetic heterogeneity in HBsAg can affect immunogenicity in acute hepatitis B infection. 122
HHV-8 genetic diversification and its impact on severe clinical presentation of associated diseases 121
Molecular and Structural Aspects of Clinically Relevant Mutations of SARS-CoV-2 RNA-Dependent RNA Polymerase in Remdesivir-Treated Patients 120
Circulation of sars-cov-2 variants in central Italy: spike variability characterization by deep-sequencing. 120
SARS-CoV-2 variants and their relevant mutational profiles: update summer 2021 117
First National Prevalence in Italian Horse Population and Phylogenesis Highlight a Fourth Sub-Type Candidate of Equine Hepacivirus 116
Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies 115
Genetic signatures specifically clustered in immune active HBsAg regions correlate with immunosuppression-driven HBV reactivation: An extensive analysis of HBV genome. 114
First Case of a COVID-19 Patient Infected by Delta AY.4 with a Rare Deletion Leading to a N Gene Target Failure by a Specific Real Time PCR Assay: Novel Omicron VOC Might Be Doing Similar Scenario? 107
Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile 107
An in-depth characterization of VOCs circulation by using NGS analysis of the Spike protein. 103
An In-Depth Characterization of SARS-CoV-2 Omicron Lineages and Clinical Presentation in Adult Population Distinguished by Immune Status 100
Epidemiological and Clinical Features of SARS-CoV-2 Variants Circulating between April–December 2021 in Italy 96
Role of low-frequency integrase strand transfer inhibitor resistance mutations on virological outcomes in antiretroviral therapy-naïve individuals initiating second-generation integrase inhibitors 95
Assessing the utilization of HIV genotype resistance testing: Insight from Italian Infectious Diseases Units 88
Genomic Epidemiology of the Main SARS-CoV-2 Variants Circulating in Italy During the Omicron Era 87
Factors predictive of multinucleoside analogue-resistance mutations in an unselected cohort of HAART-failed patients. 86
Genetic heterogenicity of HIV-1 protease in drug-naive and drug-treated HIV-positive patients 83
Factors predictive of virological response after genotyping resistance test (GRT): data from an unselected cohort 78
Leronlimab (PRO 140) in vitro activity against 4-class drug resistant HIV-1 from heavily treatment experienced subjects 78
Cross-resistance among NNRTIs: evaluation of the option of recycling Efavirenz after Nevirapine failure 74
JN.1 variants circulating in Italy from October 2023 to April 2024: genetic diversity and immune recognition 69
Identification of the Minimal Conserved Structure of the HIV-Reverse Transcriptase under the Presence and Absence of Drug Pressure 65
Long-term evaluation of the effect of genotype-based antiretroviral therapy upon virological, immunological, and clinical parameters 62
The effect of number of mutations and of drug-class sparing on virological response to salvage genotype-guided antiretroviral therapy 62
Using a database of genotype resistance tests to describe characteristics related to detection of the multinucleoside resistance-associated Q151M mutation. 59
Modulation of human immunodeficiency virus 1 replication by interferon regulatory factors 54
Using a database of HIV patients undergoing genotypic resistance test after HAART failure to understand the dynamics of M184V mutation 53
Time to detection and loss of M184 genotypic mutation among HIV patients treated with 3TC and failing an HAART regimen 52
Temporal characterization of frequency of drug-resistance associated mutations in the HIV-1 protease and reverse transcriptase 51
Development of a Next-Generation Sequencing Protocol for Assessing Lenacapavir Resistance in HIV-1 Capsid 37
null 3
Totale 17.410
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.920
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.920
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022450 0 0 0 36 20 35 26 25 123 45 24 116
2022/2023895 77 66 52 88 47 131 38 224 51 69 41 11
2023/2024323 55 5 27 16 30 85 7 11 12 18 3 54
2024/20251.647 75 357 177 144 43 80 170 76 164 131 100 130
2025/20263.019 309 121 277 311 264 110 368 394 332 214 147 172
2026/20271.069 160 123 460 326 0 0 0 0 0 0 0 0
Totale 17.410